Beihai Gofar Chuanshan Biological Co Ltd
600538
Company Profile
Business description
Beihai Gofar Chuanshan Biological Co Ltd main business include pharmaceutical manufacturing and pharmaceutical distribution industry, judicial IVD (in vitro diagnostic) technology services, molecular medical imaging centers and tumor radiotherapy centers and tumor telemedicine technology services, etc.
Contact
No. 3, Beibuwan Middle Road
Guangxi Zhuang Autonomous Region
BeihaiGuangxi536000
CHNT: +86 7793200619
Sector
Basic Materials
Stock type
Cyclical
Industry
Agricultural Inputs
Fiscal Year End
31 December 2026
Employees
453
Stocks News & Analysis
stocks
Fair value upgrade for this ASX income player
Headwinds in listed energy stocks likely to have passed
stocks
The SpaceX IPO and the Elon Musk factor
Potential investors should remember that the company’s controlling shareholder can move markets with a few words.
stocks
The ASX’s most shorted stocks in 2026
What we can and can’t learn from the top 20 most shorted ASX shares.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,632.50 | 39.90 | -0.46% |
| CAC 40 | 7,772.45 | 70.50 | 0.92% |
| DAX 40 | 22,562.88 | 262.13 | 1.18% |
| Dow JONES (US) | 45,216.14 | 49.50 | 0.11% |
| FTSE 100 | 10,127.96 | 160.61 | 1.61% |
| HKSE | 24,750.79 | 201.09 | -0.81% |
| NASDAQ | 20,794.64 | 153.72 | -0.73% |
| Nikkei 225 | 50,676.59 | 1,209.26 | -2.33% |
| NZX 50 Index | 12,732.99 | 15.93 | -0.12% |
| S&P 500 | 6,343.72 | 25.13 | -0.39% |
| S&P/ASX 200 | 8,438.80 | 38.40 | -0.45% |
| SSE Composite Index | 3,923.29 | 9.56 | 0.24% |